A New “Global Jet Lag Therapy Treatment Market” research report revealed by the Data Bridge Market research examines the overall market and presents the development status and forecast for the market in different regions around the globe.
Global Jet Lag Therapy Treatment Market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Rise in number of travelers who are traveling to different time zones and increase demand of disease specific treatment are the key factors for market growth.
Download Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-jet-lag-therapy-treatment-market
The primary research for the industry report includes information from company websites, annual reports, newspaper and database analysis presentation. It gives the detailed overview, product portfolio, financials and strategic developments for the companies analyzed in the report.
Jet lag also known as jet disorders or desynchronosis is a temporary condition of circadian rhythm sleep disorder which occurs when anyone travel across multiple time zones. Jet lag is caused when the natural biological clock of the body does not correlate with the local time zone. In jet lag disorders can demand for sleep during the day time in the new local time zone and stay awake, during late night usually when it is supposed to sleep. Jet lag may lead to fatigue, disturbance of bowel function, trouble falling asleep and tiredness.
Segmentation: Global Jet Lag Therapy Treatment Market
By Application – Business Travelers, Cabin Crew, Athletes, Seasonal Travelers and Others
By Treatment Type – Sunlight, Bright Light Therapy, Melatonin Supplements, Sleeping Pills, Exercise and Others
By Drugs – Nonbenzodiazepines, Benzodiazepines and Others
By Route of Administration – Oral and Injectable
By End-Users – Hospitals, Homecare, Specialty Clinics, Others
By Geography – North America, South America, Europe, Asia-Pacific, Middle East and Africa
Make inquiry before buying the report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-jet-lag-therapy-treatment-market
- Exposure to high altitudes and cabin pressures associated with air travel act as drivers to the market growth
- Changes in the working shift timings associated with night shifts is also expected to drive this market growth
- New launches of insomnia related products annually can boost the market growth
- Rise in number of travelers who are traveling to different time zones is propelling the market growth
- Preference of non-pharmacological therapies over pharmacological therapies are hindering the market growth
- Introduction of alternative therapy to beat the jet lag disorders is restraining the market growth
- Limited efficacy rate of available intervention is expected to restrain the growth of the market
Key Developments in the Market:
In June 2019, Clinigen Group plc received marketing authorization for Melatonin oral solution and Melatonin film coated tablet from the Medicines and Healthcare products Regulatory Agency both forms are used for the treatment of short-term treatment of jet-lag in adults. This approval will ensure efficacy and reliable treatment for patients experiencing jet lag
In December 2018, Vanda Pharmaceuticals Inc received the FDA’s acceptance for supplemental New Drug Application (sNDA) for Hetlioz (tasimelteon), melatonin receptor agonist for the treatment of jet lag disorders. It has been already approved for Non-24-Hour Sleep-Wake Disorder. If approved, it will be beneficial for those whose sleep pattern interrupted by a jet lag
Competitive Landscape and Key Players in the Global Jet Lag Therapy Treatment Market
Global jet lag therapy treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global jet lag therapy treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Among the largest key players competing in this market include Clinigen Group plc, Vanda Pharmaceuticals, Pfizer Inc, Jamieson Laboratories Ltd., NOW Foods, Nature’s Bounty, ALEXZA, Jazz Pharmaceuticals, Inc, Eisai Co., Ltd, Purdue Pharma L.P. and others.
Reasons to Purchase this Report
- Current and future of global jet lag therapy treatment market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
View Detailed Table of Content @ https://databridgemarketresearch.com/toc/?dbmr=global-jet-lag-therapy-treatment-market
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475